The risk of bleeding with duloxetine treatment in patients who use nonsteroidal anti-inflammatory drugs (NSAIDs): analysis of placebo-controlled trials and post-marketing adverse event reports

PURPOSE: To assess the safety of duloxetine with regards to bleeding-related events in patients who concomitantly did, versus did not, use nonsteroidal anti-inflammatory drugs (NSAIDs), including aspirin. METHODS: Safety data from all placebo-controlled trials of duloxetine conducted between Decembe...

Descripción completa

Detalles Bibliográficos
Autores principales: Perahia, David G, Bangs, Mark E, Zhang, Qi, Cheng, Yingkai, Ahl, Jonna, Frakes, Elijah P, Adams, Michael J, Martinez, James M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849082/
https://www.ncbi.nlm.nih.gov/pubmed/24348072
http://dx.doi.org/10.2147/DHPS.S45445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3849082/
https://www.ncbi.nlm.nih.gov/pubmed/24348072
http://dx.doi.org/10.2147/DHPS.S45445

Ejemplares similares